Trends in Psychiatry and Psychotherapy
https://trends.org.br/article/doi/10.1590/2237-6089-2016-0033
Trends in Psychiatry and Psychotherapy
Original Article

Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery

Concentração sérica de fator neurotrófico derivado do cérebro em pacientes diagnosticados com disforia de gênero que realizaram cirurgia de redesignação sexual

Maiko A. Schneider; Tahiana Andreazza; Anna Martha V. Fontanari; Angelo B. Costa; Dhiordan C. da Silva; Bianca W. de Aguiar; Raffael Massuda; Mariana Pedrini; Clarissa S. Gama; Karine Schwarz; Marcia Kauer-Sant'Anna; Maria Ines R. Lobato

http://dx.doi.org/10.1590/2237-6089-2016-0033 Trends Psychiatry Psychother, vol.39, n1, p.43-47, 2017
PDF
SciELO
Downloads: 0
Views: 494

Abstract

Abstract Introduction: Transsexualism (ICD-10) is a condition characterized by a strong and persistent dissociation with one's assigned gender. Sex reassignment surgery (SRS) and hormone therapy provide a means of allowing transsexual individuals to feel more congruent with their gender and have played a major role in treatment over the past 70 years. Brain-derived neurotrophic factor (BDNF) appears to play a key role in recovery from acute surgical trauma and environmentally mediated vulnerability to psychopathology. We hypothesize that BDNF may be a biomarker of alleviation of gender incongruence suffering. Objectives: To measure preoperative and postoperative serum BDNF levels in transsexual individuals as a biomarker of alleviation of stress related to gender incongruence after SRS. Methods: Thirty-two male-to-female transsexual people who underwent both surgery and hormonal treatment were selected from our initial sample. BDNF serum levels were assessed before and after SRS with sandwich enzyme linked immunosorbent assay (ELISA). The time elapsed between the pre-SRS and post-SRS blood collections was also measured. Results: No significant difference was found in pre-SRS or post-SRS BDNF levels or with relation to the time elapsed after SRS when BDNF levels were measured. Conclusion: Alleviation of the suffering related to gender incongruence after SRS cannot be assessed by BDNF alone. Surgical solutions may not provide a quick fix for psychological distress associated with transsexualism and SRS may serve as one step toward, rather than as the conclusion of, construction of a person's gender identity.

Keywords

Transsexualism, sex reassignment surgery, BDNF

Resumo

Resumo Introdução: O transexualismo (CID-10) é uma condição caracterizada por forte e persistente dissociação com o gênero atribuído. A cirurgia de redesignação sexual (CRS) e a terapia hormonal (TH) permitem que indivíduos transexuais se sintam mais congruentes com seu gênero e, por isso, têm desempenhado papel importante nos últimos 70 anos. O fator neurotrófico derivado do cérebro (BDNF) parece desempenhar um papel fundamental na recuperação do trauma cirúrgico agudo e vulnerabilidade ambiental à psicopatologia. Nós hipotetizamos que o BDNF pode ser um biomarcador de alívio do sofrimento de incongruência de gênero pós-CRS. Objetivos: Mensurar os níveis séricos de BDNF no pré e pós-operatório em indivíduos transexuais como biomarcador de alívio de estresse relacionado à incongruência de gênero após a CRS. Métodos: Trinta e duas pessoas transexuais masculino para feminino submetidas a cirurgia e tratamento hormonal foram selecionadas de nossa amostra inicial. O nível sérico de BDNF foi avaliado antes e depois da CRS pela técnica ELISA. O tempo decorrido entre as coletas de sangue pré e pós-CRS foi medido. Resultados: Não houve diferença significativa nos níveis de BDNF pré e pós-CRS ou em relação ao tempo decorrido entre a CRS e a coleta. Conclusão: O alívio do sofrimento relacionado à incongruência de gênero pós-CRS não pode ser avaliado apenas pelo BDNF. Soluções cirúrgicas podem não fornecer uma solução rápida para o sofrimento associado ao transexualismo, e a CRS pode servir como um passo em direção à, em vez de conclusão da, construção da identidade de gênero de uma pessoa.

Palavras-chave

Transexualismo, cirurgia de redesignação sexual, BDNF

References

Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J. Standards of care (SOC) for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13:165-232.

Hoshiai M, Matsumoto Y, Sato T, Ohnishi M, Okabe N, Kishimoto Y. Psychiatric comorbidity among patients with gender identity disorder. Psychiatry Clin Neurosci. 2010;64:514-9.

Dhejne C, Lichtenstein P, Boman M, Johansson AL, Långström N, Landén M. Long-term follow-up of transsexual persons undergoing sex reassignment surgery cohort study in Sweden. PLoS One. 2011;6:e16885.

Kuhn A, Bodmer C, Stadlmayr W, Kuhn P, Mueller MD, Birkhäuser M. Quality of life 15 years after sex reassignment surgery for transsexualism. Fertil Steril. 2009;92:1683-9.

Lobato MI, Koff WJ, Manenti C, da Fonseca Seger D, Salvador J, da Graça Borges Fortes M. Follow-up of sex reassignment surgery in transsexuals a Brazilian cohort. Arch Sex Behav. 2006;35:711-5.

Matsumoto Y, Sato T, Ohnishi M, Kishimoto Y, Terada S, Kuroda S. Stress-coping strategies of patients with gender identity disorder. Psychiatry Clin Neurosci. 2009;63:715-20.

Fernandes BS, Gama CS, Kauer-Sant'Anna M, Lobato MI, Belmonte-de-Abreu P, Kapczinski F. Serum brain-derived neurotrophic factor in bipolar and unipolar depression a potential adjunctive tool for differential diagnosis. J Psychiatr Res. 2009;43:1200-4.

Grande I, Fries GR, Kunz M, Kapczinski F. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig. 2010;7:243-50.

Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995;15:1768-77.

Shaltiel G, Chen G, Manji HK. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol. 2007;7:22-6.

Schmidt HD, Banasr M, Duman RS. Future antidepressant targets neurotrophic factors and related signaling cascades. Drug Discov Today Ther Strateg. 2008;5:151-6.

Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257-69.

Köhler S, Klimke S, Hellweg R, Lang UE. Serum brain-derived neurotrophic factor and nerve growth factor concentrations change after alcohol withdrawal preliminary data of a case-control comparison. Eur Addict Res. 2013;19:98-104.

Heberlein A, Dürsteler-MacFarland KM, Lenz B, Frieling H, Grösch M, Bönsch D. Serum levels of BDNF are associated with craving in opiate-dependent patients. J Psychopharmacol. 2011;25:1480-4.

D'Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R. Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes a prospective study. Biol Psychiatry. 2011;70:706-11.

Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 1995;92:8856-60.

Bergami M, Santi S, Formaggio E, Cagnoli C, Verderio C, Blum R. Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes. J Cell Biol. 2008;183:213-21.

Kato TA, Hayakawa K, Monji A, Kanba S. Missing and possible link between neuroendocrine factors, neuropsychiatric disorders, and microglia. Front Integr Neurosci. 2013;7:53.

Rudge JS, Pasnikowski EM, Holst P, Lindsay RM. Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid. J Neurosci. 1995;15:6856-67.

Giralt A, Friedman HC, Caneda-Ferron B, Urban N, Moreno E, Rubio N. BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. Gene Ther. 2010;17:1294-308.

Fuss J, Hellweg R, Van Caenegem E, Briken P, Stalla G, T'Sjoen G. Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF). Eur Neuropsychopharmacol. 2014;25:95-9.

Fontanari AM, Andreazza T, Costa AB, Salvador J, Koff WJ, Aguiar B. Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder. J Psychiatr Res. 2013;47:1546-8.

Kauer-Sant'Anna M, Tramontina J, Andreazza AC, Cereser K, da Costa S, Santin A. Traumatic life events in bipolar disorder impact on BDNF levels and psychopathology. Bipolar Disord. 2007;9:128-35.

Fernandes BS, Massuda R, Torres M, Camargo D, Fries GR, Gama CS. Improvement of schizophrenia with electroconvulsive therapy and serum brain-derived neurotrophic factor levels lack of association in a pilot study. Psychiatry Clin Neurosci. 2010;64:663-5.

Murad MH, Elamin MB, Garcia MZ, Mullan RJ, Murad A, Erwin PJ. Hormonal therapy and sex reassignment a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf). 2010;72:214-31.

Rehman J, Melman A. Formation of neoclitoris from glans penis by reduction glansplasty with preservation of neurovascular bundle in male-to-female gender surgery functional and cosmetic outcome. J Urol. 1999;161:200-6.

Salvador J, Massuda R, Andreazza T, Koff WJ, Silveira E, Kreische F. Minimum 2-year follow up of sex reassignment surgery in Brazilian male-to-female transsexuals. Psychiatry Clin Neurosci. 2012;66:371-2.

Baudry M, Bi X, Aguirre C. Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience. 2013;239:280-94.

García-Ovejero D, Veiga S, García-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol. 2002;450:256-71.

Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology. 2011;36:523-30.

Savic I. Asymmetry of cerebral gray and White matter and structural volumes in relation to sex hormones and chromosomes Front. Neurosci. 2014;8:329.

Hines M. Early androgen influences on human neural and behavioral development. Early Hum Dev. 2008;84:805-7.

Joel D, Berman Z, Tavor I, Wexler N, Gaber O, Stein Y. Sex beyond the genitalia the human brain mosaic. Proc Natl Acad Sci U S A. 2015;112:15468-73.

Costa AB, Fontanari AM, Andreazza T, Salvador J, Koff WJ, Aguiar B. BDNF a biomarker for social vulnerability in individuals diagnosed with gender dysphoria. J Psychiatr Res. 2014;50:16-7.

Fontanari AM, Costa AB, Aguiar B, Tusset C, Andreazza T, Schneider M. Reduced serum concentrations of brain-derived neurotrophic factor (BDNF) in transsexual Brazilian men. Neurosci Lett. 2016;630:109-13.

6169cc55a953955361267084 trends Articles
Links & Downloads
2238-0019 (Electronic)
Trends Psychiatry Psychother ©2024 All rights reserved.

Trends Psychiatry Psychother

Share this page
Page Sections